Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Oster

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 24, 2005
Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccinationC G Oster, N Kim, L Grode, et al.
Medical Care|October 1, 1991
Health-related quality of life among patients undergoing percutaneous transluminal coronary angioplastyP D Cleary, A M Epstein, G Oster, et al.
Managed Care Interface|November 29, 2001
The heptavalent conjugate pneumococcal vaccine and its implications for managed care--clinical overview and roundtable discussionsP G Alexander, S A Chartrand, T J Davies, et al.
Controlled Clinical Trials|February 1, 1995
A randomized trial to assess effectiveness and cost in clinical practice: rationale and design of the Cholesterol Reduction Intervention Study (CRIS)G Oster, G M Borok, J Menzin, et al.
Archives of Internal Medicine|April 8, 1996
Cholesterol-reduction intervention study (CRIS): a randomized trial to assess effectiveness and costs in clinical practiceG Oster, G M Borok, J Menzin, et al.
International Journal of Technology Assessment in Health Care|January 1, 1996
A multinational economic evaluation of rhDNase in the treatment of cystic fibrosisJ Menzin, G Oster, L Davies, et al.
Nouvelle Revue Francaise D'Hematologie|December 1, 1994
A phase II study of recombinant human granulocyte-colony stimulating factor (rHuG-CSF, lenograstim) in the treatment of agranulocytosis in childrenJ Donadieu, P Boutard, G Tchernia, et al.
Journal of the American College of Cardiology|May 10, 2001
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study GroupM B Fowler, M Vera-Llonch, G Oster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantationS T Sonis, G Oster, H Fuchs, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 24, 2005
Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccinationC G Oster, N Kim, L Grode, et al.
Medical Care|October 1, 1991
Health-related quality of life among patients undergoing percutaneous transluminal coronary angioplastyP D Cleary, A M Epstein, G Oster, et al.
Managed Care Interface|November 29, 2001
The heptavalent conjugate pneumococcal vaccine and its implications for managed care--clinical overview and roundtable discussionsP G Alexander, S A Chartrand, T J Davies, et al.
Controlled Clinical Trials|February 1, 1995
A randomized trial to assess effectiveness and cost in clinical practice: rationale and design of the Cholesterol Reduction Intervention Study (CRIS)G Oster, G M Borok, J Menzin, et al.
Archives of Internal Medicine|April 8, 1996
Cholesterol-reduction intervention study (CRIS): a randomized trial to assess effectiveness and costs in clinical practiceG Oster, G M Borok, J Menzin, et al.
International Journal of Technology Assessment in Health Care|January 1, 1996
A multinational economic evaluation of rhDNase in the treatment of cystic fibrosisJ Menzin, G Oster, L Davies, et al.
Nouvelle Revue Francaise D'Hematologie|December 1, 1994
A phase II study of recombinant human granulocyte-colony stimulating factor (rHuG-CSF, lenograstim) in the treatment of agranulocytosis in childrenJ Donadieu, P Boutard, G Tchernia, et al.
Journal of the American College of Cardiology|May 10, 2001
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study GroupM B Fowler, M Vera-Llonch, G Oster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantationS T Sonis, G Oster, H Fuchs, et al.
Pageof 17